Gaulin, Charles http://orcid.org/0000-0001-6943-4614
Harris, Zoey
Kodama, Rich
Shah, Monika
Blair, Janis
Wang, Yucai
Lin, Yi
Muñoz, Javier
Article History
Accepted: 4 March 2023
First Online: 18 March 2023
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: Dr. Gaulin reports personal fees from DeciBio, outside the submitted work. Dr. Harris has nothing to disclose. Dr. Kodama has nothing to disclose. Dr. Shah has nothing to disclose. Dr. Blair has nothing to disclose. Dr. Wang reports grants and personal fees from lncyte, grants and personal fees from lnnoCare, grants and personal fees from Loxo Oncology, grants and personal fees from Eli Lilly, grants from MorphoSys, grants from Novartis, grants from Genentech, grants from Genmab, personal fees from TG Therapeutics, personal fees from Kite, personal fees from Jansen, and personal fees from BeiGene, outside the submitted work. Dr. Lin reports grants and personal fees from Kite/Gilead, grants and personal fees from Celgene/BMS, personal fees from Juno/BMS, grants and personal fees from bluebird bio, grants and personal fees from Janssen, grants and personal fees from Legend Biotech, personal fees from Gamida Cells, personal fees from Novartis, personal fees from Iovance, personal fees from Takeda, personal fees from Fosun Kite, personal fees and other from Pfizer, grants from Merck, grants from Boston Scientific, other from Sorrento, and other from NexImmune, outside the submitted work. Dr. Munoz reports grants and personal fees from Pharmacyclics/AbbVie, grants and personal fees from Bayer, grants and personal fees from Gilead/Kite Pharma, personal fees from Pfizer, grants and personal fees from Janssen, personal fees from Juno/Celgene, personal fees from BMS, personal fees from Kyowa, personal fees from Alexion, personal fees from Fosun Kite, personal fees from Innovent, grants and personal fees from Seattle Genetics, personal fees from Debiopharm, personal fees from Karyopharm, personal fees from Genmab, personal fees from ADC Therapeutics, personal fees from Epizyme, personal fees from BeiGene, personal fees from Servier, personal fees from Novartis, personal fees from MorphoSys/Incyte, personal fees from Secura Bio, personal fees from TG Therapeutics, personal fees from MEI, personal fees from Lilly/Loxo, grants from Celgene, grants from Merck, grants from Portola, grants from Incyte, grants from Genentech, grants from Millennium, personal fees from Targeted Oncology, personal fees from OncView, personal fees from Curio, personal fees from Physicians’ Education Resource, personal fees from Pharmacyclics/Janssen, personal fees from Acrotech/Aurobindo, personal fees from Pharmacyclics, personal fees from Verastem, personal fees from AstraZeneca, personal fees from Celgene/BMS, and personal fees from Genentech/Roche, outside the submitted work.